BioMarin CEO expects 'substantial' profitability after FDA approval of hemophilia drug

BioMarin CEO expects 'substantial' profitability after FDA approval of hemophilia drug

CNBC Television

55 лет назад

2,273 Просмотров

Jim Cramer chats with Jean-Jacques Bienaimé, chairman and CEO of BioMarin, which focuses on therapies to treat rare diseases.

Тэги:

#CNBC #Mad_Money #invest #investing #stock_market #jim_cramer #cramer #kramer #wall_street #lightning_round #investment_strategy #retirement
Ссылки и html тэги не поддерживаются


Комментарии: